SUBSCRIBE
SUBSCRIBE

Antisoma PLC Interim Management Statement

April 29, 2008 | 
1 min read

Phase I study of ASA404 initiated in Japan London, UK: 29 April 2008 - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today publishes its interim management statement for the period from 1 January to 28 April 2008.

Europe
MORE ON THIS TOPIC
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Layoffs
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
December 19, 2024
 · 
1 min read
 · 
Annalee Armstrong
Sep 17, 2020 Fremont / CA / USA - Novo Nordisk headquarters in Silicon Valley; Novo Nordisk A/S is a Danish multinational pharmaceutical company
Manufacturing
Novo Deepens Denmark Commitment With $1.2B Rare Disease Production Facility
December 16, 2024
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone collage. Concept of contracting, negotiation, contracting, favorable terms. Trendy modern retro illustration on business theme. Concept of teamwork. Vector illustration
Mergers & acquisitions
Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition
December 16, 2024
 · 
2 min read
 · 
Tristan Manalac
Novo Nordisk advertising flags and logo on facade
Regulatory
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
December 12, 2024
 · 
1 min read
 · 
Kate Goodwin